Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-04-000055
Filing Date
2004-07-02
Accepted
2004-07-02 17:11:59
Documents
2
Period of Report
2004-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4235
2 gabrielipoa.htm EX-24 2977
  Complete submission text file 0000874015-04-000055.txt   9167
Mailing Address 2292 FARADAY AVE CARLSBAD CA 92008
Business Address 2292 FARADAY AVE CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1865 PALMER AVE, SUITE 104 LARCHMONT NY 10538
Business Address 2292 FARADAY AVENUE CARLSBAD CA 92008 760-603-2471
GABRIELI CHRISTOPHER (Reporting) CIK: 0001181553 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 04900689